Circadian Variations in Exsorptive Transport: In Situ Intestinal Perfusion Data and In Vivo Relevance

The circadian timing system (CTS) governs the 24-h rhythm of the organism and, hence, also main pathways responsible for drug pharmacokinetics. P-glycoprotein (P-gp) is a drug transporter that plays a pivotal role in drug absorption, distribution, and elimination, and temporal changes in its activity may affect input, output, activity, and toxicity profile of drugs. In the current study, the influence of different circadian stages on the overall intestinal permeability (P_eff) of the P-gp substrates talinolol and losartan was evaluated in in situ intestinal perfusion studies in rats. Additionally, in vivo studies in rats were performed by employing the P-gp probe talinolol during the day (nonactive) and night (active) period in rats. Effective intestinal permeabilities of talinolol and losartan were smaller in studies performed during the night (p?<?.05), indicating that P-gp–dependent intestinal secretion is greater during the nighttime activity span than daytime rest span of the animals. P-gp modulators vinblastine and PSC833 led to a significant decrease of talinolol and losartan exsorption in the intestinal segments as compared with control groups. Strikingly, the permeability-enhancing effect of vinblastine and PSC833 was higher with night perfusions, for both talinolol and losartan. In vivo studies performed with talinolol revealed—consistent with the in situ studies (P_eff day?>?night)—a day vs. night difference in the oral availability of talinolol in the group of male rats in terms of the area under the curve (AUC) data (AUC_day?>?AUC_night). The P-gp modulator vinblastine significantly increased talinolol AUC_day (p?<?.05), whereas only a weak vinblastine effect was seen in night. According to the in situ data, the functional activity of P-gp was regulated by the CTS in jejunum and ileum, which are major intestinal segments for energy-dependent efflux. In conclusion, circadian rhythms may affect carrier-mediated active efflux and play a role in the absorption process. In addition to daily rhythms in P-gp activity in rat intestine, the in vivo studies indicate that absorption-, distribution-, metabolism-, and elimination-relevant rhythms may be involved in the circadian kinetics of the drug, besides transporter-dependent efflux, such well-known aspects as metabolic or renal clearance or motility. Since this also holds true for a potentially interacting second compound (modulator), modulator effects should be evaluated carefully in transporter related drug-drug interactions. (Author correspondence: aokyar@istanbul.edu.tr)     

丹参红叶病发生的微生态机制

通过对丹参红叶病株与健康株根区土养分含量及根区土和根表土中的微生物区系比较,探索丹参红叶病发生的微生态机制.结果表明:丹参红叶病株叶片中N、P、K、Mn含量均显著低于健康株(P＜0.05);根区土中速效P与健康株根区土无显著差异,速效N、K含量均显著高于健康株根区土(P＜0.05),表明丹参红叶病害发生与P缺乏有关,但植株缺磷不是由于土壤供磷不足所致.丹参红叶病株根区土细菌数量较健康株减少41.3％,真菌和放线菌数量分别较健康株增加156.6％和189.5％,差异均达显著水平(P＜0.05);丹参红叶病株根表土细菌、真菌和放线菌数量变化趋势与根区土—致.在丹参红叶病株根区、根表土壤中,6种优势真菌、4种优势放线菌及2种优势细菌可能为有害微生物.优势真菌为腐皮镰刀菌、露湿漆斑菌、三线镰刀菌、焦曲霉、尖孢镰刀菌及座囊菌;优势放线菌为砖红链霉菌、威威达湖伦茨氏菌、马铃薯疮痂病原链霉菌及山丘链霉菌;优势细菌为阿氏芽孢杆菌及水生细菌.这些优势微生物可能通过影响根系生长及根系对土壤养分吸收引起丹参出现缺磷现象.表明丹参红叶病的发生与丹参根区土和根表土中微生物区系异常密切相关.     

中药甘草对大鼠肠平滑肌运动的影响

目的观察甘草对大鼠肠道平滑肌运动的影响,了解甘草与胃肠运动之间的关系。方法实验分成正常组、甘草制成煎剂4．8、16、32、64g／kg剂量组,每日1次灌胃给药。末次给药1h后观察大鼠胃半排时间;采用灌胃给予炭末,测定胃推进率。结果甘草煎剂剂量大小对大鼠小肠蠕动有直接的影响,较小剂量对大鼠小肠的推进功能有抑制作用,较大剂量对大鼠的肠推进有促进作用。     

Role of Glycoside Phosphorylases in Mannose Foraging by Human Gut Bacteria

To metabolize both dietary fiber constituent carbohydrates and host glycans lining the intestinal epithelium, gut bacteria produce a wide range of carbohydrate-active enzymes, of which glycoside hydrolases are the main components. In this study, we describe the ability of phosphorylases to participate in the breakdown of human N-glycans, from an analysis of the substrate specificity of UhgbMP, a mannoside phosphorylase of the GH130 protein family discovered by functional metagenomics. UhgbMP is found to phosphorolyze β-d-Manp-1,4-β-d-GlcpNAc-1,4-d-GlcpNAc and is also a highly efficient enzyme to catalyze the synthesis of this precious N-glycan core oligosaccharide by reverse phosphorolysis. Analysis of sequence conservation within family GH130, mapped on a three-dimensional model of UhgbMP and supported by site-directed mutagenesis results, revealed two GH130 subfamilies and allowed the identification of key residues responsible for catalysis and substrate specificity. The analysis of the genomic context of 65 known GH130 sequences belonging to human gut bacteria indicates that the enzymes of the GH130_1 subfamily would be involved in mannan catabolism, whereas the enzymes belonging to the GH130_2 subfamily would rather work in synergy with glycoside hydrolases of the GH92 and GH18 families in the breakdown of N-glycans. The use of GH130 inhibitors as therapeutic agents or functional foods could thus be considered as an innovative strategy to inhibit N-glycan degradation, with the ultimate goal of protecting, or restoring, the epithelial barrier.     

肠道菌群与疾病发生及中草药调节和治疗作用的研究概述

肠道正常菌群及微生态稳定对人体极具重要性,中草药对肠道菌群具有调节作用.本文综述了人体的肠道正常菌群与疾病产生和发展的关系,结合中草药对肠道菌群调节作用的研究,探讨中药调节肠道菌群与其发挥疾病防治效果之间的相关性,以期为中草药的临床应用及药理学研究提供一定的参考依据.     

感染华支睾吸虫大鼠肠道菌群的实验研究

目的 观察华支睾吸虫感染对大鼠肠道菌群的影响.方法 建立华支睾吸虫感染大鼠模型,分别在造模后48 h、18d和35 d,取肠内容物进行乳酸杆菌、双歧杆菌、肠球菌和肠杆菌的培养及定量分析.结果 与对照组相比,在感染后48 h,大鼠肠道乳酸杆菌和双歧杆菌数量减少(P＜0.05),肠球菌和肠杆菌数量略有增加,但差异无统计学意义(P＞0.05);在感染后18 d(童虫期),乳酸杆菌、双歧杆菌数量进一步减少(P＜0.01),肠杆菌和肠球菌数量明显增加(P＜0.01);在感染后35 d(成虫期),四种肠道菌与童虫期的变化基本一致.结论 华支睾吸虫感染可致大鼠肠道菌群发生失调,其中益生菌减少,致病菌增多,尤以童虫期、成虫期较重.     

砂仁对抗生素所致肠道菌群失调小鼠调节作用的探讨

【摘要】 目的 通过建立抗生素诱导小鼠肠道菌群失调模型,应用PCR-变性梯度凝胶电泳(PCR-DGGE)技术分析小鼠肠道菌群失调前后经服用中药砂仁调理后肠道菌群指纹图谱的变化。方法 选用10只昆明种小鼠,正常培养7 d,适应环境后每天取粪便1次,连续3 d;菌群稳定后按100 mg/kg的头孢拉啶灌胃,每天灌胃2次,连续5 d,每天取粪便1次;上述小鼠随机分为两个组,自然恢复组(饲喂基础饲料)和砂仁处理组,每组5只。3 d后每天取粪便1次,连续3 d,提取细菌总DNA,以16S rRNA基因V3区通用引物扩增,对扩增的PCR产物进行DGGE电泳及指纹图谱分析并切胶测序比对。结果 抗生素处理后小鼠肠道菌群与正常小鼠差异有统计学意义,致病菌增加,砂仁处理组小鼠与正常小鼠的肠道菌群指纹图谱有很大的相似性,但与自然恢复组差异有统计学意义。结论 抗生素可导致小鼠肠道菌群失调,而中药砂仁对肠道菌群失调有明显的恢复作用。     

消化道屏障与树突状细胞免疫研究进展

肠相关淋巴组织在防御病毒、细菌、寄生虫等有害物质入侵中发挥着重要作用,是消化道屏障的组成部分,其中肠道树突状细胞尤为重要,作为目前所知的机体内功能最强的专职性抗原呈递细胞,在肠道内,树突状细胞不但能对病原菌产生免疫应答,还能对肠腔内的正常菌群和各种食物蛋白产生免疫耐受,因此了解树突状细胞的功能及相关作用机制有着重要意义.现就对树突状细胞的生物学特性,以及其在肠道免疫中的作用进行综述.     

肠道微生物群落与炎症性肠病关系研究进展

目的炎症性肠病（IBD）包括克罗恩病（CD）和溃疡性结肠炎（UC）,以持续性肠道非特异性炎症为特征,通常反复发作、迁延不愈,临床上仍无特效性的治疗手段。IBD确切的发病机制尚不清楚,涉及免疫、环境及遗传等因素,这些因素共同诱导肠道炎症、黏膜损伤和修复。肠道微生物群落及其代谢产物、宿主基因易感性及肠道黏膜免疫三方面共同参与了IBD的发病机制。本文从消化道微生态角度出发,对目前IBD相关的肠道微生物群落研究现状、宿主-微生物间免疫应答及益生菌治疗等内容进行探讨。     

双歧杆菌四联活菌片对肝硬化白发性细菌性腹膜炎患者肠黏膜屏障和炎症因子的影响

目的探讨双歧杆菌四联活菌片对肝硬化自发性细菌性腹膜炎（SBP）患者肠黏膜屏障和炎症因子的影响。方法选择乙肝后肝硬化SBP患者68例,分为治疗组和对照组。两组患者均予以低盐饮食、护肝利尿、补充白蛋白和抗感染等基础治疗。治疗组在此基础上予以双歧杆菌四联活菌片口服,1．5g／次,3次／d,连用6周。结果治疗6周后,两组血浆内毒素、PCT和尿L／M比值比较均有明显下降（对照组比较P〈0．05,或治疗组比较P〈0．01）,且治疗组下降幅度明显优于对照组（P〈0．05）;两组血浆TNF-α、IL-6和IL-10水平均有明显下降（对照组比较P〈0．05,或治疗组比较P〈0．01）,且治疗组下降幅度明显优于对照组（P〈0．05）。治疗组临床总有效率明显高于对照组（χ2=8．17,P〈0．01）,治疗期间未发生严重的药物不良反应。结论双歧杆菌四联活菌片治疗肝硬化SBP患者具有较好的临床疗效及安全性,对患者肠黏膜屏障功能具有良好保护和改善作用,并能下降血浆TNF—α、IL-6和IL-10水平,具有辅助治疗肝硬化作用。